The Business of Biotech was back in San Francisco for JPM in January, and offers here a few observations, highlights, and ...

Amgen Inc. (NASDAQ:AMGN) is one of the stocks on Jim Cramer’s recent game plan. Cramer said that he heard good things about the company during the JPMorgan Healthcare Conference, as he commented: With ...

Senti Biosciences, Inc. (Nasdaq: SNTI) ('Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today ...

Across all industries, the total number of companies on track to go public could make this week the most active for IPOs since 2021.

The initiative uses microgravity and extreme conditions to speed up medical discoveries and turn them into startups.

Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript February 2, 2026 Twist Bioscience Corporation ...

Well, the first half of 2025 certainly threw a bit of a curveball at the pharma and biotech sectors. Despite a steady stream of new drug approvals and ongoing innovation, things didn’t quite follow ...